These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 9465437)

  • 41. Wilms' tumor in adults: results of the Society of Pediatric Oncology (SIOP) 93-01/Society for Pediatric Oncology and Hematology (GPOH) Study.
    Reinhard H; Aliani S; Ruebe C; Stöckle M; Leuschner I; Graf N
    J Clin Oncol; 2004 Nov; 22(22):4500-6. PubMed ID: 15542800
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Assessment of the resectability of Wilms' tumors in childhood].
    Schaarschmidt K; Ritter J; Willital GH; Olesczcuk-Raschke K; Kindhäuser V; Stratmann U
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():1084-90. PubMed ID: 9101787
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Risk factors for perioperative complications in renal surgery for Wilms' tumor].
    Seseke F; Rebmann S; Zöller G; Lakomek M; Ringert RH
    Aktuelle Urol; 2007 Jan; 38(1):46-51. PubMed ID: 17290329
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A rare case of adult Wilms' tumor.
    Ngo TC; Clark CJ; Zhao G; Reese JH
    Can J Urol; 2011 Feb; 18(1):5568-9. PubMed ID: 21333056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current therapy for Wilms' tumor.
    Metzger ML; Dome JS
    Oncologist; 2005; 10(10):815-26. PubMed ID: 16314292
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
    J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential expression of the drug resistance markers DNA topoisomerase II alpha and glutathione S-transferase-pi in the histological compartments of Wilms' tumors.
    Granzen B; Efferth T; Keller U; Beniers AJ; Mertens R; Jakse G; Füzesi L
    Anticancer Res; 2001; 21(1B):771-6. PubMed ID: 11299842
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anaplastic Wilms' tumor. Initial diagnosis by fine needle aspiration.
    Drut R; Pollono D
    Acta Cytol; 1987; 31(6):774-6. PubMed ID: 2827412
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metachronous bilateral Wilms' tumor, National Wilms' Tumor Study.
    Jones B; Hrabovsky E; Kiviat N; Breslow N
    Am J Clin Oncol; 1982 Oct; 5(5):545-50. PubMed ID: 6295133
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prognostic factors in Wilms' tumor].
    Bezanilla JL; González Casaseca T
    An Esp Pediatr; 1985 Aug; 23(2):125-9. PubMed ID: 2998250
    [No Abstract]   [Full Text] [Related]  

  • 51. Wilms' tumor associated with Moyamoya disease: a case report.
    Watanabe Y; Todani T; Fujii T; Toki A; Uemura S; Koike Y
    Z Kinderchir; 1985 Apr; 40(2):114-6. PubMed ID: 2988231
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Wilms' tumor, pancreatic islet cell carcinoma, and pheochromocytoma in a child.
    Sola JE; Gutierrez JC; Thompson WR; Alvarez OA; Casillas J; Rodriguez MM
    J Pediatr Surg; 2008 Mar; 43(3):E25-9. PubMed ID: 18358270
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Glomerulus-like structures in Wilms' tumor].
    Sokolova IN
    Arkh Patol; 1984; 46(12):36-42. PubMed ID: 6098244
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study.
    Metzger ML; Stewart CF; Freeman BB; Billups CA; Hoffer FA; Wu J; Coppes MJ; Grant R; Chintagumpala M; Mullen EA; Alvarado C; Daw NC; Dome JS
    J Clin Oncol; 2007 Jul; 25(21):3130-6. PubMed ID: 17634492
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anaplastic Wilms' tumor: clinical and pathologic studies.
    Bonadio JF; Storer B; Norkool P; Farewell VT; Beckwith JB; D'Angio GJ
    J Clin Oncol; 1985 Apr; 3(4):513-20. PubMed ID: 2984344
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Der(16)t(1;16)(q21;q13) in Wilms' tumor: friend or foe.
    Mathew P; Douglass EC; Jones D; Valentine M; Valentine V; Rowe S; Shapiro DN
    Med Pediatr Oncol; 1996 Jul; 27(1):3-7. PubMed ID: 8614388
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nonviable tumor tissue should not upstage Wilms' tumor from stage I to stage II: a report from the SIOP 93-01 nephroblastoma trial and study.
    Vujanić GM; Harms D; Bohoslavsky R; Leuschner I; de Kraker J; Sandstedt B
    Pediatr Dev Pathol; 2009; 12(2):111-5. PubMed ID: 18811224
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Tumors in children. I. Wilms' tumor].
    Becht E
    Urologe A; 1990 Jul; 29(4):W29-34. PubMed ID: 2169083
    [No Abstract]   [Full Text] [Related]  

  • 59. [Wilms tumor in adults. Case description].
    Segura Martín M; Lorenzo Romero J; Salinas Sánchez A; Hernández Millán I; Ruiz Mondéjar R; Iñiguez de Onzoño L; Virseda Rodríguez J
    Arch Esp Urol; 1998 Sep; 51(7):705-8. PubMed ID: 9807897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.
    Safford SD; Freemerman AJ; Langdon S; Bentley R; Goyeau D; Grundy PE; Skinner MA
    J Pediatr Surg; 2005 Feb; 40(2):341-8. PubMed ID: 15750927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.